7.320
+0,00%
2026-10-12
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +120.5% | +41.7% | 2 / 3 | +33.2% | -1.23 pp | +1.68 pp | +5.0% | 0.44 | 8.94 | 66,5 | +33,2% | 2,8 | +120,5% | 8.94 | 13.55 | −34,0% |
| Pts | 12 | 8 | 8 | 12 | 4 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 7.320 (close price on 2026-10-12)EPS (TTM): 818,5
Financial charts
1.Revenue & growth
VND bn66,5Q2/26
1.Revenue & growth
VND bn66,5Q2/26
2.Profit & growth
VND bn2,82Q2/26
3.Profit mix (Penman)
VND bn10,1Q2/26
4.Margins & cost structure
%9.3%Q2/26
5.Returns & cash cycle
% · days0.4%Q2/26
6.Earnings quality & cash
VND bn5,01Q2/26
7.Asset structure
VND bn269Q2/26
8.Funding & debt health
VND bn · times269Q2/26
9.Revenue backlog
VND bn2,27Q2/26
10.Valuation
times · %8,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %271Q2/26
Adjusted EPS growth, latest quarter
121%
Average adjusted EPS growth, 3 quarters
41.7%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26